Beyond TP53 and EGFR, IDH wildtype glioblastoma frequently exhibit a spectrum of additional genomic alterations, affecting genes such as PTEN, CDKN2A/B, and RB1 [62]. This evidence concerns the gene IDH2 and glioblastoma.